Aprogen pharmaceuticals,Inc. (KOSE:A003060) agreed to acquire Aprogen Biologics Inc. from Aprogen, Inc. on October 4, 2022. The deal is subject to Aprogen pharmaceuticals,Inc. (KOSE:A003060) board approval. As of October 4, 2022 Aprogen pharmaceuticals,Inc. (KOSE:A003060) board approved the deal.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,011 KRW | +0.60% |
|
-3.71% | -65.14% |
1st Jan change | Capi. | |
---|---|---|
-65.14% | 48.05M | |
+51.85% | 823B | |
+39.44% | 641B | |
-6.16% | 352B | |
+16.49% | 324B | |
+7.65% | 301B | |
+13.79% | 241B | |
+1.72% | 223B | |
+13.02% | 218B | |
+7.04% | 167B |
- Stock Market
- Equities
- A003060 Stock
- News Aprogen Biologics Inc.
- Aprogen pharmaceuticals,Inc. agreed to acquire Aprogen Biologics Inc. from Aprogen, Inc.